Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment.
In a retrospective cohort analysis, loss to follow-up and mortality rates were compared between pregnant and nonpregnant women referred to a community-based antiretroviral treatment program in South Africa. Although there was no significant difference in adjusted mortality rates between the two groups, the pregnant women had a substantially higher risk of loss to follow-up both pretreatment and on-treatment. This finding highlights the need for programmatic interventions to address retention in care for this patient population.
Kaplan
Richard
R
The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Richard.Kaplan@hiv-research.org.za
Orrell
Catherine
C
Zwane
Eugene
E
Bekker
Linda-Gail
LG
Wood
Robin
R
D000293:Adolescent; D000328:Adult; D000554:Ambulatory Care Facilities; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D016022:Case-Control Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology*; D006801:Humans; D010352:Patient Dropouts; D011247:Pregnancy; D037841:Pregnant People / Q000523:psychology*; D012189:Retrospective Studies; D013019:South Africa
D044966:Anti-Retroviral Agents